Great Minds from Medtech Gather at Medtec China; Discover Opportunities in the Rapidly Evolving Medical Device Market

Medtec China 2020 will be held from September 14-16 at SWEECC Halls 2&4 this year, "MDiT Forum and Regulation Summit 2020" is also going to return, continuing to focus on "regulations, quality and technology," joining hands with medical device industry authorities and experts, to bring a unique industry education opportunity. More than 900 professional delegates and 60 speakers are getting together to discuss and seize the opportunities in the rapidly evolving medical device market in China.

All the great minds from the Medtech field get together at Medtec China

The "MDiT Forum and Regulation Summit" brings local and international experts from the Medtech field and technical principals of medical devices leading companies. Keynote speakers from NIFDC, Tianjin Medical Devices Supervision and Testing Center CFDA, CCCMHPIE, SHFDA's Division of Medical Device Registration, JSDA, GDMDT, FDA China, Shenzhen Mindray Bio-Medical Electronics Co.,Ltd have been invited to attend. 

Regulatory & Quality Changes and Technology Development focus

This year's "Chinese Regulatory Updates and Compliance" will interpret the latest updates of regulatory hotspots. Especially after going through the COVID-19 pandemic, insight from experts about "what is the future of the medical device industry" is very crucial. Topics such as "Listing Permit Holder System in China updates", " Medical Device e-registration workflow", "Latest process of special inspection of Innovative Medical Devices", and "Standard of molecular diagnosis reagent industry" will be discussed. 

Quality Track A will still focus on "Management of Medical Product Life Cycle" and analyze the risk and quality management of medical device products over the entire life cycle from the perspective of manufacturers. Quality Track B will discuss "FDA's Shift from 21 CFR 820 Toward ISO 13485: 2016 and FDA factory inspection" and analyze the changes that will result from the FDA's change in quality regulatory system and its impact on factory inspections.

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the reproduced articles,

please email: Julia.Zhang@ubmsinoexpo.com to motify or remove the content.